Evommune, Inc. current ratio

The Current Ratio as of November 2026 (TTM) for Evommune, Inc. (EVMN) is 11.68

According to Evommune, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 11.68. This represents a change of -3.62% compared to the average of 12.12 of the last 4 quarters.

Evommune, Inc. (EVMN) Historical Current Ratio (quarterly & annually)

How has EVMN Current Ratio performed in the past?

The mean historical Current Ratio of Evommune, Inc. over the last ten years is 7.63. The current 11.68 Current Ratio has changed 53.11% with respect to the historical average. Over the past ten years (40 quarters), EVMN's Current Ratio was at its highest in in the March 2026 quarter at 20.36. The Current Ratio was at its lowest in in the March 2024 quarter at 0.

Evommune, Inc. (EVMN) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Evommune, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Evommune, Inc. (EVMN) Average Current Ratio

How has EVMN Current Ratio performed in the past?

The current Current Ratio of Evommune, Inc. (EVMN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Evommune, Inc. (EVMN) Current Ratio vs. Peers

How is EVMN’s Current Ratio compared to its peers?

Evommune, Inc.’s Current Ratio is less than Artiva Biotherapeutics, Inc. (24.16), greater than Codexis, Inc. (3.06), less than Climb Bio, Inc. (31.45), greater than EyePoint Pharmaceuticals, Inc. (4.50), greater than Fortrea Holdings Inc. (0.97), less than Galapagos N.V. (30.48), greater than Karyopharm Therapeutics Inc. (0.79), less than Ligand Pharmaceuticals Incorporated (13.35), greater than OmniAb, Inc. (4.21), greater than Zymeworks Inc. (6.32),

Build a custom stock screener for Evommune, Inc. (EVMN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Evommune, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Evommune, Inc. (EVMN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Evommune, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.